Vir Biotechnology is a startup based in the United Kingdom, most recent round IPO, 2 tracked investors.
Vir Biotechnology is a company founded in 2016 headquartered in the United Kingdom. Its most recent tracked round is IPO. Brouky records 2 investors associated with the company.
Vir Biotechnology is a clinical-stage biotechnology company that engineers antibody-based medicines and leverages immune-system-focused platforms (including a next-generation antibody platform and the PRO-XTEN masking technology) to develop therapies for infectious diseases and oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.